Select Medical
SEM was delisted on the 30th of June, 2026.
264 hedge funds and large institutions have $4.42B invested in Select Medical in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 107 reducing their positions, and 27 closing their positions.
578% more call options, than puts
Call options by funds: $21.2M | Put options by funds: $3.13M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 27
25% more capital invested
Capital invested by funds: $3.53B → $4.42B (+$893M)
4% more funds holding
Funds holding: 255 → 264 (+9)
1.61% more ownership
Funds ownership: 142.72% → 144.33% (+1.6%)
22% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 107
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$71M |
| 2 |
O
OrbiMed
New York
|
+$49M |
| 3 |
Goldman Sachs
New York
|
+$37.7M |
| 4 |
CGM
Capital Growth Management
Boston,
Massachusetts
|
+$32.9M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$25.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$99.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.8M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$14.8M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.9M |
SEM Hedge Fund Activity: Q2 2021 in Review
264 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2021, worth a combined $4.42B — up 25% from $3.53B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new SEM positions and 27 closed out — a net gain of 9 holders — while 83 added to existing stakes and 107 trimmed.
The largest buyer was Macquarie Group, adding an estimated $71M. The largest seller was T. Rowe Price Associates, cutting an estimated $99.9M.
- 264 institutional investors held Select Medical (SEM) as of Q2 2021, up from 255 in Q1 2021.
- Funds reported $4.42B of Select Medical stock for Q2 2021, up 25% quarter-over-quarter.
- 36 funds opened new Select Medical positions in Q2 2021 and 27 closed out, a net change of +9 holders.
- The largest Select Medical buyer in Q2 2021 was Macquarie Group, an estimated $71M added.
- The largest Select Medical seller in Q2 2021 was T. Rowe Price Associates, an estimated $99.9M sold.
Based on aggregated 13F filings for Q2 2021.